Outset Medical Inc. (OM)’s quick and current ratios


After finishing at $12.31 in the prior trading day, Outset Medical Inc. (NASDAQ: OM) closed at $12.25, down -0.49%. On the day, 540636 shares were traded.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.



Our goal is to gain a better understanding of OM by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.40 and its Current Ratio is at 6.30. In the meantime, Its Debt-to-Equity ratio is 0.53 whereas as Long-Term Debt/Eq ratio is at 0.53.

Upgrades & Downgrades

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 01 when Ahmed Nabeel sold 545 shares for $13.61 per share. The transaction valued at 7,417 led to the insider holds 89,171 shares of the business.

Trigg Leslie sold 3,028 shares of OM for $45,723 on Aug 16. The Chair and CEO now owns 406,461 shares after completing the transaction at $15.10 per share. On Aug 16, another insider, Ahmed Nabeel, who serves as the Chief Financial Officer of the company, sold 1,565 shares for $15.10 each. As a result, the insider received 23,632 and left with 89,171 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OM now has a Market Capitalization of 609.93M and an Enterprise Value of 490.55M. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.80 while its Price-to-Book (P/B) ratio in mrq is 3.28. Its current Enterprise Value per Revenue stands at 4.15 whereas that against EBITDA is -3.10.

Stock Price History:

Over the past 52 weeks, OM has reached a high of $30.55, while it has fallen to a 52-week low of $11.41. The 50-Day Moving Average of the stock is 16.19, while the 200-Day Moving Average is calculated to be 20.98.

Shares Statistics:

The stock has traded on average 517.65K shares per day over the past 3-months and 502.07k shares per day over the last 10 days, according to various share statistics. A total of 48.95M shares are outstanding, with a floating share count of 48.39M. Insiders hold about 1.10% of the company’s shares, while institutions hold 111.05% stake in the company. Shares short for OM as of Aug 30, 2023 were 7.65M with a Short Ratio of 7.65M, compared to 8.29M on Jul 30, 2023. Therefore, it implies a Short% of Shares Outstanding of 15.37% and a Short% of Float of 18.13%.

Earnings Estimates

Its stock is currently analyzed by 4 different market analysts. On average, analysts expect EPS of -$0.71 for the current quarter, with a high estimate of -$0.69 and a low estimate of -$0.74, while EPS last year was -$0.85. The consensus estimate for the next quarter is -$0.71, with high estimates of -$0.67 and low estimates of -$0.74.

Analysts are recommending an EPS of between -$2.79 and -$2.88 for the fiscal current year, implying an average EPS of -$2.83. EPS for the following year is -$2.34, with 4 analysts recommending between -$1.28 and -$2.8.

Revenue Estimates

6 analysts predict $36.03M in revenue for the current quarter. It ranges from a high estimate of $36.24M to a low estimate of $35.5M. As of the current estimate, Outset Medical Inc.’s year-ago sales were $27.76M, an estimated increase of 29.80% from the year-ago figure. For the next quarter, 6 analysts are estimating revenue of $39.14M, an increase of 22.30% less than the figure of $29.80% in the same quarter last year. There is a high estimate of $40.77M for the next quarter, whereas the lowest estimate is $38.37M.

A total of 7 analysts have provided revenue estimates for OM’s current fiscal year. The highest revenue estimate was $146.4M, while the lowest revenue estimate was $144M, resulting in an average revenue estimate of $144.62M. In the same quarter a year ago, actual revenue was $115.38M, up 25.30% from the average estimate. Based on 7 analysts’ estimates, the company’s revenue will be $195.17M in the next fiscal year. The high estimate is $203.9M and the low estimate is $188M. The average revenue growth estimate for next year is up 35.00% from the average revenue estimate for this year.


Please enter your comment!
Please enter your name here